Wells Fargo Upgraded Oceaneering International (OII); Biodelivery Sciences International (BDSI) Sellers Decreased By 1.17% Their Shorts

May 24, 2018 - By Richard Conner

Oceaneering International, Inc. (NYSE:OII) Logo

Biodelivery Sciences International Inc (NASDAQ:BDSI) had a decrease of 1.17% in short interest. BDSI’s SI was 2.72M shares in May as released by FINRA. Its down 1.17% from 2.75 million shares previously. With 734,700 avg volume, 4 days are for Biodelivery Sciences International Inc (NASDAQ:BDSI)’s short sellers to cover BDSI’s short positions. The SI to Biodelivery Sciences International Inc’s float is 6.21%. The stock decreased 1.09% or $0.025 during the last trading session, reaching $2.275. About 279,138 shares traded. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) has risen 10.53% since May 24, 2017 and is uptrending. It has underperformed by 1.02% the S&P500.

Equities researchers at Wells Fargo’s equities division increased Oceaneering International (NYSE:OII)‘s stock to “Hold” on Thursday, 24 May. The stock research analysts at Wells Fargo have a target price per share of $24.0000 on OII or 1.18% more upside.

Investors sentiment decreased to 0.88 in 2017 Q4. Its down 0.41, from 1.29 in 2017Q3. It dived, as 48 investors sold Oceaneering International, Inc. shares while 76 reduced holdings. 35 funds opened positions while 74 raised stakes. 95.10 million shares or 4.36% less from 99.43 million shares in 2017Q3 were reported. Spark Inv Mngmt Ltd reported 185,900 shares. Monroe National Bank & Tru Mi accumulated 23,653 shares. Zurcher Kantonalbank (Zurich Cantonalbank) reported 0% of its portfolio in Oceaneering International, Inc. (NYSE:OII). Aqr Mngmt Limited Liability reported 0.08% stake. Mirae Asset Global Invs has 13,133 shares. Amer Intl Group Inc accumulated 203,327 shares. Teachers Retirement Systems Of The State Of Kentucky owns 19,490 shares for 0% of their portfolio. Nikko Asset Mgmt Americas reported 0.33% of its portfolio in Oceaneering International, Inc. (NYSE:OII). First Eagle Investment Ltd Liability Corp has invested 0% of its portfolio in Oceaneering International, Inc. (NYSE:OII). Moreover, Horizon Kinetics Limited Liability Corporation has 0.04% invested in Oceaneering International, Inc. (NYSE:OII). 127,998 are owned by Opportunities Lc. Franklin Resources Incorporated reported 0.01% in Oceaneering International, Inc. (NYSE:OII). Jpmorgan Chase holds 0% or 355,968 shares. Utah Retirement Sys, a Utah-based fund reported 18,182 shares. Corecommodity Mgmt accumulated 46,471 shares.

Among 27 analysts covering Oceaneering International (NYSE:OII), 7 have Buy rating, 2 Sell and 18 Hold. Therefore 26% are positive. Oceaneering International has $69 highest and $16.0 lowest target. $28.52’s average target is 20.24% above currents $23.72 stock price. Oceaneering International had 78 analyst reports since July 23, 2015 according to SRatingsIntel. Global Hunter Securities upgraded the stock to “Buy” rating in Tuesday, July 28 report. The company was maintained on Thursday, July 20 by RBC Capital Markets. Capital One downgraded the shares of OII in report on Thursday, November 16 to “Equal-Weight” rating. The stock of Oceaneering International, Inc. (NYSE:OII) earned “Hold” rating by Gabelli on Friday, October 16. On Friday, October 27 the stock rating was maintained by Credit Suisse with “Neutral”. On Friday, August 4 the stock rating was maintained by Cowen & Co with “Hold”. RBC Capital Markets upgraded Oceaneering International, Inc. (NYSE:OII) rating on Friday, May 20. RBC Capital Markets has “Sector Perform” rating and $36 target. The rating was downgraded by Piper Jaffray on Friday, October 27 to “Hold”. The firm earned “Buy” rating on Monday, November 30 by Guggenheim. Cowen & Co maintained the stock with “Hold” rating in Friday, April 13 report.

Oceaneering International, Inc. provides engineered services and products to the offshore gas and oil, defense, aerospace, and commercial theme park industries worldwide. The company has market cap of $2.34 billion. The companyÂ’s Remotely Operated Vehicles segment offers submersible vehicles for drill support, vessel inspection, maintenance and repair, installation and construction support, pipeline inspection and surveys, and subsea production facility operation and maintenance services. It has a 14.12 P/E ratio. As of December 31, 2016, this segment owned 280 work-class ROVs.

Since December 18, 2017, it had 0 insider buys, and 1 insider sale for $5,956 activity. Another trade for 307 shares valued at $5,956 was made by MOSCHETTA ROBERT P on Monday, December 18.

Analysts await Oceaneering International, Inc. (NYSE:OII) to report earnings on July, 25. They expect $-0.26 earnings per share, down 1,400.00% or $0.28 from last year’s $0.02 per share. After $-0.41 actual earnings per share reported by Oceaneering International, Inc. for the previous quarter, Wall Street now forecasts -36.59% EPS growth.

Another recent and important Oceaneering International, Inc. (NYSE:OII) news was published by Bizjournals.com which published an article titled: “9 firms to add nearly 200 workers for tech-related jobs (Video)” on May 01, 2018.

The stock decreased 0.67% or $0.16 during the last trading session, reaching $23.72. About 738,888 shares traded. Oceaneering International, Inc. (NYSE:OII) has declined 24.59% since May 24, 2017 and is downtrending. It has underperformed by 36.14% the S&P500.

Among 7 analysts covering BioDelivery Sciences International (NASDAQ:BDSI), 7 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioDelivery Sciences International had 37 analyst reports since August 16, 2015 according to SRatingsIntel. The firm has “Buy” rating by H.C. Wainwright given on Monday, May 7. As per Wednesday, May 11, the company rating was downgraded by Cantor Fitzgerald. The rating was maintained by Piper Jaffray with “Buy” on Friday, October 20. The rating was maintained by Cantor Fitzgerald with “Buy” on Thursday, March 15. The company was maintained on Thursday, May 12 by Piper Jaffray. On Wednesday, August 9 the stock rating was maintained by Piper Jaffray with “Buy”. The firm earned “Neutral” rating on Tuesday, October 27 by Janney Capital. The stock of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) earned “Buy” rating by H.C. Wainwright on Monday, November 27. The firm has “Buy” rating by FBR Capital given on Wednesday, June 21. The stock of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) earned “Mkt Perform” rating by FBR Capital on Tuesday, November 10.

BioDelivery Sciences International, Inc., a specialty pharmaceutical company, engages in the development and commercialization of pharmaceutical products principally in the areas of pain management and addiction. The company has market cap of $134.85 million. The firm provides its products based on its patented BioErodible MucoAdhesive drug delivery technology, which consists of a small, erodible polymer film for application to the buccal mucosa. It has a 25.28 P/E ratio. It offers ONSOLIS, a fentanyl buccal soluble film to treat breakthrough pain in opioid patients with cancer; BUNAVAIL, a buprenorphine and naloxone buccal film for the treatment of opioid dependence; and BELBUCA, a buprenorphine buccal film for the treatment of chronic pain.

More notable recent BioDelivery Sciences International, Inc. (NASDAQ:BDSI) news were published by: Nasdaq.com which released: “BioDelivery Sciences to Present at the Jefferies 2018 Global Healthcare Conference” on May 23, 2018, also Nasdaq.com with their article: “BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as …” published on May 22, 2018, Bizjournals.com published: “Broadfin pumps $50M into Raleigh’s BDSI” on May 17, 2018. More interesting news about BioDelivery Sciences International, Inc. (NASDAQ:BDSI) were released by: Bizjournals.com and their article: “Raleigh pharma ushers in new CEO from Allergan” published on May 08, 2018 as well as Bizjournals.com‘s news article titled: “BDSI closes $50M equity financing – here’s what its board looks like now” with publication date: May 22, 2018.

Investors sentiment increased to 2.13 in 2017 Q4. Its up 0.46, from 1.67 in 2017Q3. It improved, as 4 investors sold BioDelivery Sciences International, Inc. shares while 11 reduced holdings. 15 funds opened positions while 17 raised stakes. 22.65 million shares or 11.32% more from 20.34 million shares in 2017Q3 were reported. Archford Cap Strategies Ltd Limited Liability Company has 0.04% invested in BioDelivery Sciences International, Inc. (NASDAQ:BDSI) for 40,000 shares. Ameriprise Incorporated reported 0% of its portfolio in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Hikari Power Ltd holds 601,285 shares. Citigroup holds 0% or 1,000 shares. Bailard has invested 0.1% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Barclays Public Ltd Llc owns 72,386 shares for 0% of their portfolio. Janney Montgomery Scott Ltd holds 48,466 shares or 0% of its portfolio. Alphamark Ltd Llc accumulated 0% or 1,100 shares. Wells Fargo And Mn invested in 0% or 67,081 shares. Salem Inv Counselors reported 0.01% stake. Weiss Asset Mgmt Limited Partnership reported 0.01% stake. Baker Bros Advsrs Ltd Partnership invested 0.01% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Moreover, Gsa Cap Prns Ltd Liability Partnership has 0.07% invested in BioDelivery Sciences International, Inc. (NASDAQ:BDSI) for 408,667 shares. California-based Venbio Select Advisor Limited Liability Company has invested 0.47% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI). Natl Bank Of Montreal Can invested 0% in BioDelivery Sciences International, Inc. (NASDAQ:BDSI).

Since January 2, 2018, it had 0 insider buys, and 4 sales for $2.52 million activity. On Tuesday, January 2 the insider Sirgo Mark A sold $1.94 million. Shares for $243,223 were sold by ODONNELL FRANCIS E JR. De Paolantonio Ernest Robert also sold $134,013 worth of BioDelivery Sciences International, Inc. (NASDAQ:BDSI) on Tuesday, April 3.

Oceaneering International, Inc. (NYSE:OII) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Richard Conner

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: